Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA name
CircHIPK3
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-330-5p/RASSF1
Cancer name
Pancreatic Cancer
Cancer site
qRT-PCR,Western blot,Dual-luciferase assay
Treatment type
Chemotherapy
Drug
Gemcitabine
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
CircHIPK3 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1
Tissue resource
cancer tissues and adjacent tissues of patients with PC
human prostate cancer cell lines PANC-1
human prostate cancer cell lines SW 1990
Experiment
None
Institute
Third Xiangya Hospital, Central South University
Cell Collection Committee of the Chinese Academy of Sciences
Country
China
China
Continent
Asia
Asia
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.